This study looks at whether taking nilotinib for two years can help people with chronic myeloid leukemia (CML) stay in remission after stopping their medication a second or third time. About 75 adults who previously tried and failed to stop treatment will take nilotinib and then …
Phase: PHASE2 • Sponsor: European LeukemiaNet • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC